Stockreport

Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference

Theriva Biologics, Inc.  (TOVX) 
PDF ROCKVILLE, Md., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Theriva Biologics, Inc. (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed [Read more]